Confirmed Conference Session Titles
Day 1:
SESSION ONE: Patient engagement
SESSION TWO: Patient engagement and clinical trial considerations in ultra-rare patient groups
SESSION THREE: Global Neuromuscular Care and Trial Considerations
Day 2:
SESSION FOUR: COVID impact on Outcomes, Care & Clinical Trial Design
SESSION FIVE: Living with NMD: practical considerations and QOL
SESSION SIX: Emerging Therapeutics options in NMD
SESSION SEVEN: Future of clinical trial Design
Our full 2022 programme will be coming soon.
For announcements, see the TREAT-NMD Newsletter, sign up here:
Venue
Vancouver Convention Centre
1055 Canada Pl,
Vancouver,
British Columbia
V6C 0C3,
Canada
